(Q58808890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

L J Scully

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

R Shein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

J A McDonald

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

H C Thomas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 August 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

51-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Effect of Vidarabine on Chronic Hepatitis B Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Antiviral therapy in hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Determinants for hepatitis B e antigen clearance in chronic type B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

The spectrum of immunologic abnormalities and clinical findings in homosexually active men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

Immunoregulatory T cell subsets in chronic hepatitis B virus infection: the influence of homosexuality.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980061-2

7 January 2021

10.1016/S0168-8278(87)80061-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3655310%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference